Sino Biological's cutting-edge recombinant cytokines for research and therapeutics : Get Quote, RFQ, Price or Buy news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
Bispecific antibodies are fast becoming a hot topic for research and development. ACROBiosystems offer a variety of protein targets for bispecific antibody research.
High-quality Fc receptor proteins are crucial for determining the efficacy of antibodies. ACROBiosystems roster of Fc receptors provides the ultimate in terms of verification and purity.
As biosimilars are becoming more and more popular, the need to ensure their safety is paramount. ACROBiosystem’s range of biosimilar drug targets, mainly antigen receptor proteins and Fc receptor proteins are thus highly useful.
Multiple myeloma is a common hematological malignancy that has its origins in plasma cells. Despite treatment becoming more sophisticated, there is still currently no cure. However, immunotherapy targeting CD38/CD3 is proving to be very promising.